Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort

Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Marco H, Callaway, Natalia F, Greven, Margaret A, Vail, Daniel, Moshfeghi, Darius M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200391/
https://www.ncbi.nlm.nih.gov/pubmed/32431486
http://dx.doi.org/10.2147/OPTH.S250361
_version_ 1783529324459065344
author Ji, Marco H
Callaway, Natalia F
Greven, Margaret A
Vail, Daniel
Moshfeghi, Darius M
author_facet Ji, Marco H
Callaway, Natalia F
Greven, Margaret A
Vail, Daniel
Moshfeghi, Darius M
author_sort Ji, Marco H
collection PubMed
description Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.
format Online
Article
Text
id pubmed-7200391
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72003912020-05-19 Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort Ji, Marco H Callaway, Natalia F Greven, Margaret A Vail, Daniel Moshfeghi, Darius M Clin Ophthalmol Short Report Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment. Dove 2020-04-29 /pmc/articles/PMC7200391/ /pubmed/32431486 http://dx.doi.org/10.2147/OPTH.S250361 Text en © 2020 Ji et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Short Report
Ji, Marco H
Callaway, Natalia F
Greven, Margaret A
Vail, Daniel
Moshfeghi, Darius M
Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_full Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_fullStr Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_full_unstemmed Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_short Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_sort telemedicine follow-up for intravitreal bevacizumab injection in the stanford university network for diagnosis of retinopathy of prematurity (sundrop) cohort
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200391/
https://www.ncbi.nlm.nih.gov/pubmed/32431486
http://dx.doi.org/10.2147/OPTH.S250361
work_keys_str_mv AT jimarcoh telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
AT callawaynataliaf telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
AT grevenmargareta telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
AT vaildaniel telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
AT moshfeghidariusm telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort

Ejemplares similares